Packaging of positive-strand RNA virus replicon particles

Details for Australian Patent Application No. 2001293222 (hide)

Owner Wyeth Holdings Corporation

Inventors Kowalski, Jacek; Kovacs, Gerald R.; Vasilakis, Nikos; Zamb, Timothy

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001293222

PCT Pub. Number WO02/18585

Priority 60/228,906 29.08.00 US

Filing date 28 August 2001

Wipo publication date 13 March 2002

Acceptance publication date 20 September 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

C07K 14/08 (2006.01) Peptides having more than 20 amino acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C12N 7/01 (2006.01) Viruses, e.g. bacteriophages - Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material

C12N 7/02 (2006.01) Viruses, e.g. bacteriophages - Recovery or purification

C12N 9/12 (2006.01) Enzymes, e.g. ligases (6.) - transferring phosphorus containing groups, e.g. kinases (2.7)

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

C12N 15/863 (2006.01) Mutation or genetic engineering - Poxviral vectors, e.g. vaccinia virus

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

20 September 2007 Application Accepted

  Published as AU-B-2001293222

17 January 2008 Standard Patent Sealed

26 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001293223

2001293221